Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697720 · ClinicalTrials.gov registry record · Phase 4
Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain
A Phase 4 study, sponsored by Endeavor Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT03697720 is a Phase 4 study that has completed, run by Endeavor Health. The registered enrollment target is 26 participants.
The verdict
NCT03697720, a Phase 4 study, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goal of this study is to see if optimized use of naproxen for treatment of dysmenorrhea will improve pain report from baseline. In addition, we will determine whether cross-organ influences from the uterus on bladder pain sensitivity change from baseline after reduced menstrual pain experience over six months. Finally, a battery of quantitative sensory tests and EEG measures of sensory sensitivity will be used to evaluate mechanisms associated with improvements in menstrual and bladder pain.
Interventions
- DRUG Naproxen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-05-09 |
| Est. Completion | 2023-09-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03697720
The ClinicalTrials.gov registry entry for NCT03697720 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naproxen is the first listed.
NCT03697720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03697720 about?
NCT03697720 is a clinical study titled "Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain". The goal of this study is to see if optimized use of naproxen for treatment of dysmenorrhea will improve pain report from baseline. In addition, we will determine whether cross-organ influences from the uterus on bladder pain sensitivity change from baseline after reduced menstrual pain experience o...
What is the current status of trial NCT03697720?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2018-05-09. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT03697720?
The interventions under investigation include: Naproxen (DRUG).
Who is sponsoring clinical trial NCT03697720?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.